180 related articles for article (PubMed ID: 34222257)
21. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
[TBL] [Abstract][Full Text] [Related]
22. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
23. Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells.
Ma Y; Mao G; Wu G; Chen M; Qin F; Zheng L; Zhang XE
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24477-24486. PubMed ID: 33961399
[TBL] [Abstract][Full Text] [Related]
24. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
25. Sialylation of host proteins as targetable risk factor for COVID-19 susceptibility and spreading: A hypothesis.
Bongiovanni A; Cusimano A; Annunziata I; d'Azzo A
FASEB Bioadv; 2021 Mar; 3(3):192-197. PubMed ID: 33733058
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
28. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
29. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
Hati S; Bhattacharyya S
ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
[TBL] [Abstract][Full Text] [Related]
30. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
Verkhivker G
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
32. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
33. The Manifold Roles of Sphingolipids in Viral Infections.
Avota E; Bodem J; Chithelen J; Mandasari P; Beyersdorf N; Schneider-Schaulies J
Front Physiol; 2021; 12():715527. PubMed ID: 34658908
[TBL] [Abstract][Full Text] [Related]
34. Irradiation accelerates SARS-CoV-2 infection by enhancing sphingolipid metabolism.
Wei Z; Jiang Y; Zhao G; Li C; Han S; Chen Y; Wang T; Cheng T; Wang J; Wang C
J Med Virol; 2023 Jan; 95(1):e28266. PubMed ID: 36319186
[TBL] [Abstract][Full Text] [Related]
35. Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.
Alkafaas SS; Abdallah AM; Hassan MH; Hussien AM; Elkafas SS; Loutfy SA; Mikhail A; Murad OG; Elsalahaty MI; Hessien M; Elshazli RM; Alsaeed FA; Ahmed AE; Kamal HK; Hafez W; El-Saadony MT; El-Tarabily KA; Ghosh S
BMC Public Health; 2024 Feb; 24(1):395. PubMed ID: 38321448
[TBL] [Abstract][Full Text] [Related]
36. Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids.
Meacci E; Pierucci F; Garcia-Gil M
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625805
[TBL] [Abstract][Full Text] [Related]
37. The acid sphingomyelinase/ceramide system in COVID-19.
Kornhuber J; Hoertel N; Gulbins E
Mol Psychiatry; 2022 Jan; 27(1):307-314. PubMed ID: 34608263
[TBL] [Abstract][Full Text] [Related]
38. Sars-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte-Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia.
Balzanelli MG; Distratis P; Dipalma G; Vimercati L; Inchingolo AD; Lazzaro R; Aityan SK; Maggiore ME; Mancini A; Laforgia R; Pezzolla A; Tomassone D; Pham VH; Iacobone D; Castrignano A; Scarano A; Lorusso F; Tafuri S; Migliore G; Inchingolo AM; Nguyen KCD; Toai TC; Inchingolo F; Isacco CG
Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442710
[TBL] [Abstract][Full Text] [Related]
39. The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2.
Fenizia S; Gaggini M; Vassalle C
Curr Issues Mol Biol; 2023 Sep; 45(10):7956-7973. PubMed ID: 37886946
[TBL] [Abstract][Full Text] [Related]
40. Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries.
Kurano M; Jubishi D; Okamoto K; Hashimoto H; Sakai E; Morita Y; Saigusa D; Kano K; Aoki J; Harada S; Okugawa S; Doi K; Moriya K; Yatomi Y
J Biomed Sci; 2022 Nov; 29(1):94. PubMed ID: 36357929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
